Early increase of TNFα and IL-6 in tracheobronchial aspirate fluid indicator of subsequent chronic lung disease in preterm infants

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 77, Issue 3, 1997, Pages

  Jónsson, Baldvin ^a   Tullus, Kjell ^a   Brauner, Annelie ^b   Lu, Ying ^b   Noack, Gerd ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Department of Anaesthesiology ^*

Author keywords

Chronic lung disease; Cytokines; Mechanical ventilation; Tracheobronchial aspirate fluid

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8; LUNG SURFACTANT EXTRACT; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ARTIFICIAL VENTILATION; CHRONIC LUNG DISEASE; EARLY DIAGNOSIS; HUMAN; NEWBORN; PATHOPHYSIOLOGY; PATIENT SELECTION; PREDICTION; PREGNANCY; PREMATURITY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RESPIRATORY DISTRESS SYNDROME; RISK FACTOR; UREAPLASMA UREALYTICUM;

EID: 0031419892     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/fn.77.3.F198     Document Type: Article

References (26)

1. Northway W. An introduction to bronchopulmonary dysplasia. Clin Perinatol 1992;19:489-95.
2. deLemos R, Coalson J. The contribution of experimental models to our understanding of the pathogenesis and treatment of bronchopulmonary dysplasia. Clin Perinatol 1992;19:521-39.
3. Arnon S, Grigg J, Silverman M. Pulmonary inflammatory cells in ventilated preterm infants: Effect of surfactant treatment. Arch Dis Child 1993;69:44-8.
4. Kelley J. Cytokines of the lung. Am Rev Respir Dis 1990;141:765-88.
5. Groneck P, Speer C. Inflammatory mediators and bronchopulmonary dysplasia. Arch Dis Child 1995;73:F1-F3.
6. Bagchi A, Viscardi R, Taciak V, Ensor J, McCrea K, Hasday J. Increased activity of Interleukin-6 but not tumor necrosis factor-a in lung lavage of premature infants is associated with the development of bronchopulmonary dysplasia. Pediatr Res 1994;36:244-52.
7. Groneck P, Speer C. Interleukin-8 in pulmonary effluent fluid of preterm infants. J Pediatr 1993;123:839-40.
8. McColm J, McIntosh N. Interleukin-8 in bronchoalveolar lavage samples as predictor of chronic lung disease in premature infants. Lancet 1993;343:729.
9. Tullus K, Noack G, Burman L, Nilsson R, Wretlind B, Brauner A. Elevated cytokine levels in tracheobronchial aspirate fluids from ventilator treated neonates with bronchopulmonary dysplasia. Eur J Pediatr 1996;155:112-16.
10. Hjalmarsson O. Epidemiology and classification af acute neonatal respiratory disorders. Acta Paediatr Scand 1981;70:773-83.
11. Watterberg K, Demers L, Scott S, Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996;97:210-15.
12. Groneck P, Götze-Speer B, Oppermann M, Eiffert H, Speer C. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates. Pediatrics 1994;93:712-18.
13. Watts C, Fanaroff A, Bruce M. Elevation of fibronectin levels in lung secretions of infants with respiratory distress syndrome and development of bronchopulmonary dysplasia. J Pediatr 1992;120:614-20.
14. Gonzalez A, Sosenko IRS, Chandar J, Hummler H, Cleure N, Bancalari E. Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less. J Pediatr 1996;128:470-8.
15. Jones C, Cayabyab R, Kwong K, et al. Undetectable interleukin (IL)-10 and persistent IL-8 expression in early hyaline membrane disease: a possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns. Pediatr Res 1996;39:966-75.
16. Groneck P, Goetze-Speer B, Speer C. Inflammatory bronchopulmonary response of preterm infants with microbial colonization of the airways at birth. Arch Dis Child 1996;74:F51-5.
17. Grigg J, Barber A, Silverman M. Increased levels of bronchoalveolar lavage fluid interleukin-6 in preterm infants ventilated after prolonged rupture of membranes. Am Rev Respir Dis 1992;145:782-6.
18. Munshi U, Niu J, Siddiq M, Parton L. Tracheal aspirate Interleukin-8 elevation followed by Interleukin-6 precede the appearance of neutrophils in preterm neonates who develop bronchopulmonary dysplasia. Pediatr Res 1996;39 (part 2):232A.
19. Murch S, MacDonald T, Wood C, Costeloe K. Tumor necrosis factor in the bronchoalveolar secretions of infants with the respiratory distress syndrome and the effect of dexamethasone treatment. Thorax 1992;47:44-7.
20. Rozycki H Bronchoalveolar Interleukin-1ß in infants on day 1 of life. South Med J 1994;87:991-6.
21. Merritt T. Oxygen exposure in the newborn guinea pig lung lavage cell populations. Chemotactic and elastase response: a possible relationship to neonatal bronchopulmonary dysplasia. Pediatr Res 1982;16:798-805.
22. Merritt T, Cochrane C, Holcomb K, et al. Elastase and alproteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. J Clin Invest 1983;72:656-66.
23. Sherman M, Laurie A, Campbell T. Effect of different surfactants on pulmonary group B streptococcal infection in premature rabbits. J Pediatr 1994;125:939-47.
24. Speer C, Götze B, Curstedt T, Robertsson B. Phagocytic functions and tumor necrosis factor secretion of human monocytes exposed to natural porcine surfactant (Curosurf). Pediatr Res 1991;30:69-74.
25. Ehrenkranz R, Mercurio M. Bronchopulmonary dysplasia. In: Sinclair J, Bracken M, eds. Effective Care of the Newborn Infant. Oxford: Oxford University Press, 1992: 399-424.
26. Silverman M Chronic lung disease of prematurity: are we to cautious with steroids? Eur J Pediatr 1994;153:S30-5.